Objective: To examine how women use the nuchal translucency (NT) risk adjustment in decision-making for invasive prenatal diagnosis.
Study Design: Retrospective cohort study of 1083 consecutive NT screening exams. A screen-positive test was defined as a risk > or = 1/300.